We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
Cap. Flow
+$802M
Cap. Flow %
0.75%
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$78.7M
2
XYZ
Block Inc
XYZ
+$49.3M
3
V icon
Visa
V
+$46.1M
4
AAPL icon
Apple
AAPL
+$45.4M
5
DASH icon
DoorDash
DASH
+$45.1M

Sector Composition

Rank Sector Weight
1 Technology 28.67%
2 Financials 14.43%
3 Healthcare 10.97%
4 Consumer Discretionary 10.82%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIST icon
3176
Vista Energy
VIST
$7.32B
$65.7K ﹤0.01%
1,411
-2,653
-65% -$137K
PRPL icon
3177
Purple Innovation
PRPL
$41.7M
$65.4K ﹤0.01%
3,445
-256
-7% -$5.9K
TCI icon
3178
Transcontinental Realty Investors
TCI
$323M
$65.1K ﹤0.01%
2,331
-77
-3% -$2.17K
KVYO icon
3179
Klaviyo
KVYO
$4.73B
$65.1K ﹤0.01%
2,151
+100
+5% +$4.03K
OKLO
3180
Oklo
OKLO
$8.42B
$64.9K ﹤0.01%
+3,000
New +$101K
NNDM
3181
Nano Dimension
NNDM
$343M
$64.5K ﹤0.01%
40,587
+18,889
+87% +$42.8K
SDX
3182
DELISTED
SODEXHO ALLIANCE SA ADS (REP 1 COM SHR)
SDX
$64.3K ﹤0.01%
5,035
HQI icon
3183
HireQuest
HQI
$185M
$64.3K ﹤0.01%
5,404
+636
+13% +$8.59K
MBX
3184
MBX Biosciences
MBX
$3.27B
$64.3K ﹤0.01%
8,712
-760
-8% -$8.04K
HLVX
3185
DELISTED
HilleVax
HLVX
$64.2K ﹤0.01%
44,294
-2,234
-5% -$4.13K
LCUT icon
3186
Lifetime Brands
LCUT
$211M
$63.9K ﹤0.01%
12,967
+448
+4% +$2.43K
APLT
3187
DELISTED
Applied Therapeutics
APLT
$63.4K ﹤0.01%
129,700
-4,635
-3% -$2.73K
LXRX icon
3188
Lexicon Pharmaceuticals
LXRX
$1.1B
$63.3K ﹤0.01%
137,230
-15,921
-10% -$10K
OEF icon
3189
iShares S&P 100 ETF
OEF
$20.6B
$63.1K ﹤0.01%
233
-200
-46% -$57.4K
XBIT icon
3190
XBiotech
XBIT
$69.2M
$63.1K ﹤0.01%
19,467
-277
-1% -$955
GIL icon
3191
Gildan
GIL
$10.6B
$62.9K ﹤0.01%
1,423
VALU icon
3192
Value Line
VALU
$361M
$62.1K ﹤0.01%
1,607
-146
-8% -$6.01K
BLUE
3193
DELISTED
bluebird bio
BLUE
$61.1K ﹤0.01%
12,522
-1,654
-12% -$9.95K
KYTX icon
3194
Kyverna Therapeutics
KYTX
$484M
$61K ﹤0.01%
31,614
+5,694
+22% +$16.8K
NAUT icon
3195
Nautilus Biotechnolgy
NAUT
$115M
$60K ﹤0.01%
69,755
-3,628
-5% -$5.39K
CRML icon
3196
Critical Metals Corp
CRML
$1.06B
$59.8K ﹤0.01%
43,047
+36,740
+583% +$167K
ANRO icon
3197
Alto Neuroscience
ANRO
$1.11B
$58.6K ﹤0.01%
27,127
+1,571
+6% +$5.62K
TLYS icon
3198
Tilly's
TLYS
$128M
$58.5K ﹤0.01%
26,573
+585
+2% +$2.15K
JBIO
3199
Jade Biosciences
JBIO
$1.34B
$57.1K ﹤0.01%
650
+262
+68% +$23K
NOVA
3200
DELISTED
Sunnova Energy
NOVA
$56.8K ﹤0.01%
152,799
-23,499
-13% -$45.2K

Similar funds

RhumbLine Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
  • RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
  • RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
  • RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
  • RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
  • RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
  • RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.

Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.